The synergistic anticancer effect of salinomycin combined with cabazitaxel in CD44+ prostate cancer cells by downregulating wnt, NF-κB and AKT signaling.

Suat Erdogan Riza Serttas Kader Turkekul Ilker Dibirdik

Published in: Molecular biology reports (2022)

In conclusion, our data suggest that combining salinomycin with cabazitaxel shows promise as a prostate cancer treatment approach that can target CSCs.

Keyphrases

cancer stem cells
signaling pathway
cell proliferation
big data
prostate cancer
pi k akt
electronic health record
stem cells
lps induced
benign prostatic hyperplasia
oxidative stress
cancer therapy
machine learning
nuclear factor
artificial intelligence
data analysis
deep learning